| Today's Open | $104.26 |
|---|---|
| Previous Close | $104.24 |
| Daily Range | $103.62 - $107.40 |
| 52-Week Range | $67.61 - $114.95 |
| Market Cap | $78.4B |
| P/E Ratio | 17.61 |
| Dividend (Yield) | $1.88 (1.8%) |
| Ex-Dividend Date Dividend Pay Date |
05/14/13 06/07/13 |
| Volume | 3,535,198 |
| Average Daily Volume | 4,042,980 |
| Current FY EPS | $7.19 |
Sector
Healthcare
Industry
Drugs
Amgen, Inc. (AMGN) Description
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/
News & Commentary
Oncolytics announces successful tests for cancer drug Reolysin.
Can Financial Innovation Unlock a Cure for Cancer?
Andrew W. Lo from the MIT Sloan School of Management has a rather Foolish idea for solving the world's biggest problems.
These three stocks embraced volatility today as investors sold off.
AMGN's Top Competitors
(0.28%)
(-0.96%)
(-0.05%)
